azacitidine and Autoimmune Disease

azacitidine has been researched along with Autoimmune Disease in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (17.65)18.2507
2000's3 (17.65)29.6817
2010's10 (58.82)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Itani, K; Kai, Y; Kohno, K; Kondo, Y; Matsumoto, M; Miura, G; Nakayama, T; Saburi, M; Soga, Y1
Dasanu, CA; Kaur, J; Tuler, S1
Aisa, Y; Fujita, Y; Ito, C; Masuda, K; Mori, T; Nakazato, T; Osada, Y1
Balog, A; Block, JA; Bukiej, AA; Glant, TT; Jolly, M; Kovács, L; Markovics, A; Mikecz, K; Ocskó, T; Rauch, TA; Ruthberg, AD; Tóth, DM; Vida, A1
Al Ustwani, O; Ambrus, J; Barcos, M; Block, AM; Ford, LA; Griffiths, EA; Sait, SJ; Thompson, JE; Vigil, CE; Wang, ES; Wetzler, M1
Fu, Y; Hu, Z; Kuang, N; Min, W; Shu, K; Zhang, Y; Zhang, Z1
Al Ali, NH; Bart-Smith, E; Craig, BM; Epling-Burnette, PK; Komrokji, RS; Kordasti, S; Kulasekararaj, A; Lancet, JE; List, AF; Mufti, GJ; Padron, E; Pinilla-Ibarz, J; Zhang, L1
Aouba, A; Arlet, JB; Berthier, S; Braun, T; Buchdahl, AL; Decaux, O; Denis, G; Fain, O; Fenaux, P; Fraison, JB; Gardin, C; Grignano, E; Kahn, JE; Leon, N; Liozon, E; Lortholary, O; Maigne, G; Mekinian, A; Omouri, M; Park, S; Rossignol, J1
Bottinger, EP; Bromberg, JS; Ding, Y; Ju, W; Lal, G; Levy, DE; Reid, SP; van der Touw, W; Zhang, N1
Al Ustwani, O; Ambrus, J; Francis, J; Wallace, PK; Wetzler, M1
Doleris, LM; Dreyfus, F; Park, S; Pilorge, S1
Bazanis, E; Benopoulou, O; Diamantopoulos, PT; Meletis, J; Michael, M; Tzeletas, G; Vayopoulos, G; Viniou, NA1
Richardson, B1
Erf, GF; Smyth, JR; Sreekumar, GP1
Ambady, S; Ponce de Leon, FA; Smyth, JR; Sreekumar, GP1
Izui, S; Merino, R; Shibata, T; Yoshida, H; Yoshida, M1
Csordas, A; Dietrich, H; Krömer, G; Schauenstein, K; Wick, G1

Reviews

2 review(s) available for azacitidine and Autoimmune Disease

ArticleYear
Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.
    Leukemia research, 2013, Volume: 37, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Autoimmune Diseases; Azacitidine; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Prognosis; Treatment Outcome; Young Adult

2013
DNA methylation and autoimmune disease.
    Clinical immunology (Orlando, Fla.), 2003, Volume: 109, Issue:1

    Topics: Animals; Autoimmune Diseases; Autoimmunity; Azacitidine; Cell Communication; DNA Methylation; Humans; Hydralazine; In Vitro Techniques; Lupus Erythematosus, Systemic; Models, Immunological; Procainamide; T-Lymphocytes

2003

Other Studies

15 other study(ies) available for azacitidine and Autoimmune Disease

ArticleYear
[Successful treatment of myelodysplastic syndrome-associated autoinflammatory lymphedema with azacytidine].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Volume: 60, Issue:12

    Topics: Aged, 80 and over; Autoimmune Diseases; Azacitidine; Female; Humans; Lymphedema; Myelodysplastic Syndromes; Pancytopenia

2019
Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:7

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Azacitidine; Female; Humans; Myelodysplastic Syndromes; Pancytopenia

2021
A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
    Annals of hematology, 2018, Volume: 97, Issue:10

    Topics: Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Autoimmune Diseases; Azacitidine; Early Diagnosis; Factor V; Factor V Deficiency; Gingival Hemorrhage; Humans; Immunosuppressive Agents; Male; Partial Thromboplastin Time; Prednisone; Prothrombin Time

2018
Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine.
    Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:8

    Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Azacitidine; B-Lymphocytes; Chromatin Immunoprecipitation; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Flow Cytometry; Gene Silencing; Mice

2019
Therapeutic effect of daphnetin on the autoimmune arthritis through demethylation of proapoptotic genes in synovial cells.
    Journal of translational medicine, 2014, Oct-14, Volume: 12

    Topics: Animals; Annexin A5; Apoptosis; Arthritis, Experimental; Autoimmune Diseases; Azacitidine; Cell Survival; DNA Methylation; Gene Expression Regulation; Necrosis; Propidium; Rats; Synovial Membrane; Umbelliferones

2014
Autoimmune diseases and myelodysplastic syndromes.
    American journal of hematology, 2016, Volume: 91, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azacitidine; Comorbidity; Disease Progression; Disease Susceptibility; Female; Follow-Up Studies; Hashimoto Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Kaplan-Meier Estimate; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Prevalence; Proportional Hazards Models; Retrospective Studies; Thalidomide; Thyroiditis, Autoimmune; Young Adult

2016
Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Leukemia research, 2016, Volume: 43

    Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azacitidine; Female; Humans; Inflammation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies

2016
Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation.
    Journal of immunology (Baltimore, Md. : 1950), 2009, Jan-01, Volume: 182, Issue:1

    Topics: Animals; Autoimmune Diseases; Azacitidine; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Colitis; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Forkhead Transcription Factors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; T-Lymphocytes, Regulatory

2009
Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cells.
    Leukemia research, 2011, Volume: 35, Issue:5

    Topics: Adult; Antimetabolites, Antineoplastic; Autoimmune Diseases; Azacitidine; Blood Cell Count; Down-Regulation; Humans; Huntington Disease; Lupus Erythematosus, Systemic; Male; Myelodysplastic Syndromes; T-Lymphocytes, Regulatory

2011
The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases.
    British journal of haematology, 2011, Volume: 153, Issue:5

    Topics: Aged; Autoimmune Diseases; Azacitidine; Humans; Immunologic Factors; Male; Middle Aged; Myelodysplastic Syndromes

2011
Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.
    Virology journal, 2012, Jan-03, Volume: 9

    Topics: Anti-Retroviral Agents; Antimetabolites, Antineoplastic; Autoimmune Diseases; Azacitidine; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Polymerase Chain Reaction; Treatment Outcome

2012
5-azacytidine treatment induces autoimmune vitiligo in parental control strains of the Smyth line chicken model for autoimmune vitiligo.
    Clinical immunology and immunopathology, 1996, Volume: 81, Issue:2

    Topics: Animals; Autoimmune Diseases; Azacitidine; Body Weight; Chickens; Disease Models, Animal; Erythrocyte Count; Feathers; Incidence; Leukocyte Count; Lymphocyte Activation; Lymphoid Tissue; Organ Size; Vitiligo

1996
Analysis of the effect of endogenous viral genes in the Smyth line chicken model for autoimmune vitiligo.
    The American journal of pathology, 2000, Volume: 156, Issue:3

    Topics: Animals; Autoimmune Diseases; Azacitidine; Blotting, Northern; Chickens; Deoxyribonuclease HindIII; Deoxyribonucleases, Type II Site-Specific; Disease Models, Animal; DNA; DNA Fingerprinting; DNA Methylation; Endogenous Retroviruses; Female; Fibroblasts; Genes, Viral; In Situ Hybridization, Fluorescence; Male; Pedigree; Polymorphism, Restriction Fragment Length; RNA Viruses; RNA, Viral; Vitiligo

2000
5-Azacytidine inhibits the lpr gene-induced lymphadenopathy and acceleration of lupus-like syndrome in MRL/MpJ-lpr/lpr mice.
    European journal of immunology, 1990, Volume: 20, Issue:9

    Topics: Animals; Autoantibodies; Autoimmune Diseases; Azacitidine; Female; Immunoglobulin G; Immunosuppressive Agents; Lupus Nephritis; Lymphoproliferative Disorders; Mice; Mice, Inbred BALB C; Survival Rate; T-Lymphocytes

1990
In-vivo treatment with 5-azacytidine causes degeneration of central lymphatic organs and induces autoimmune disease in the chicken.
    International journal of experimental pathology, 1991, Volume: 72, Issue:3

    Topics: Animals; Autoimmune Diseases; Azacitidine; Body Weight; Bone Marrow; Chickens; Lymphatic Diseases; Lymphoid Tissue; Organ Size; Organ Specificity

1991